Target intelligence / Profile preview

Long intergenic non-protein coding RNA 279 (LINC00279)

Target: LINC00279
Molecular classification: Long non-coding RNA (lncRNA)

Overview

Long intergenic non-protein coding RNA 279 (LINC00279) is a gene that encodes a long non-coding RNA. This class of RNA does not code for proteins and is usually implicated in regulation of gene expression through transcriptional, post-transcriptional, or epigenetic mechanisms. LINC00279 is catalogued in human genomic databases (e.g., HGNC, Gencode, NCBI Gene) and is identifiable by the symbol LINC00279 and the alias NCRNA00279. As of now, its specific biological role, disease associations, or utility as a therapeutic target or biomarker have not been established.

Other names: NCRNA00279

Mechanism of action

Not applicable. No drugs target LINC00279.

Biological functions

At present, there are no well-documented biological functions attributed to LINC00279. It may be involved in transcriptional or epigenetic regulation, as is common for lncRNAs, but specific functions have not been characterized in the literature.

Disease associations

None specifically documented; there is currently no clear evidence associating LINC00279 with cancer, inflammation, neurodegenerative disease, cardiovascular disease, infection, or other pathologies.

Safety considerations

None reported; LINC00279 is not a therapeutic target and carries no documented safety concerns.

Interacting drugs

None reported; no drugs are known to interact directly with LINC00279.

Biomarkers

None reported; LINC00279 is not established as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 279 (LINC00279).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 279 (LINC00279).

Explore the full profile